TGAN Insider Trading Activity and SEC Form 4 Filings
TGAN insider trading summary
No open-market insider purchases or sales of Transphorm, Inc. (TGAN) have been reported on SEC Form 4 in the past 12 months.
Latest TGAN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 20, 2024 | Henry R Kravis | Insider | Sell | $124.5M (24,411,968 @ $5.10) |
| Jun 20, 2024 | George R Roberts | Insider | Sell | $124.5M (24,411,968 @ $5.10) |
| Jun 20, 2024 | KKR & Co. Inc. | Insider | Sell | $124.5M (24,411,968 @ $5.10) |
| Jun 20, 2024 | KKR Phorm Investors L.P. | Insider | Sell | $124.5M (24,411,968 @ $5.10) |
| Jun 20, 2024 | KKR Phorm Investors GP LLC | Insider | Sell | $124.5M (24,411,968 @ $5.10) |
| Jun 20, 2024 | KKR Group Partnership L.P. | Insider | Sell | $124.5M (24,411,968 @ $5.10) |
| Jun 20, 2024 | KKR Group Holdings Corp. | Insider | Sell | $124.5M (24,411,968 @ $5.10) |
| Jun 20, 2024 | KKR Group Co. Inc. | Insider | Sell | $124.5M (24,411,968 @ $5.10) |
| Jun 20, 2024 | KKR Management LLP | Insider | Sell | $124.5M (24,411,968 @ $5.10) |
| May 22, 2024 | Katharina G. McFarland | Insider | Sell | $20K (3,996 @ $4.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.